The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / November / Tracking Tumor Cell Damage With Raman Spectroscopy
Spectroscopy News and Research

Tracking Tumor Cell Damage With Raman Spectroscopy

Gold nanostar sensors monitored pH changes linked to cell damage in a 3D-printed breast cancer model

11/12/2026 2 min read
  • Full Article
  • Summary
  • Takeaways
  • Listen
  • Scorecard
  • Quiz
  • Poll

Share

Clinical Scorecard: Tracking Tumor Cell Damage With Raman Spectroscopy

At a Glance

CategoryDetail
ConditionBreast cancer cell damage and local pH changes in an in vitro 3D tissue model
Key MechanismsPolymer-coated gold nanostars functionalized with a pH-responsive Raman reporter provide ratiometric surface-enhanced Raman scattering (SERS) measurements; spectral mapping and machine-learning analysis track pH changes associated with cell membrane damage.
Target PopulationBreast cancer cells in a 3D-printed hydrogel scaffold; the study is an in vitro methods investigation, not a clinical patient study.
Care SettingLaboratory research using engineered 3D breast cancer models to study treatment response, cell viability, and local chemical changes.

Key Highlights

  • Researchers loaded breast cancer cells with pH-responsive SERS nanotags before placing them on a 3D-printed hydrogel scaffold.
  • The models were exposed to a chemotherapeutic agent, a cytotoxic surfactant, and light-induced plasmonic heating.
  • SERS detected pH increases after each treatment, with timing varying from minutes to days depending on the stimulus.
  • Independent cytotoxicity testing linked the pH increases with cell membrane damage.
  • SERS maps provided subcellular spatial resolution across three-dimensional regions measuring several millimeters.

Guideline-Based Recommendations

Diagnosis

  • The study used changes in the Raman reporter’s spectral bands as a ratiometric measure of local pH.
  • Machine-learning analysis identified pH-related spectral changes and tracked their distribution through the models.

Management

  • The article describes an experimental measurement platform and does not provide clinical treatment recommendations.

Monitoring & Follow-up

  • The approach mapped pH changes across 3D regions after chemical treatment or plasmonic heating.
  • The authors identify calibration stability, sensor-to-sensor variation, and performance in more complex models as areas for future assessment.

Risks

  • The article identifies potential biological effects of the nanotags as an issue requiring further assessment.
  • The reported findings are from an in vitro model and do not establish clinical performance.

Patient & Prescribing Data

No patients were studied; the experiments used breast cancer cells in an in vitro 3D-printed hydrogel model.

The models were exposed to a chemotherapeutic agent, a cytotoxic surfactant, and light-induced plasmonic heating. No prescribing or patient treatment data are reported.

Clinical Best Practices

  • Independent cytotoxicity testing linked the observed pH increases with cell membrane damage.
  • The study reports an in vitro measurement platform and does not report clinical validation.
  • The authors identify calibration stability, sensor-to-sensor variation, nanotag biological effects, and performance in models with additional cell types and extracellular components as areas for future assessment.

Related Resources & Content

This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #3
Spectroscopy
The Analytical Scientist Innovation Awards 2024: #3

December 6, 2024

4 min read

Bruker’s multiphoton microscopy module, OptoVolt, ranks third in our Innovation Awards. Here, Jimmy Fong, product development lead, walks us through the major moments during development.

More Bang for Your Buck
Spectroscopy
More Bang for Your Buck

December 4, 2024

1 min read

Researchers develop more stable catalysts for dry reforming of methane – a promising method for carbon capture and utilization (CCU)

The Analytical Scientist Innovation Awards 2024: #1
Spectroscopy
The Analytical Scientist Innovation Awards 2024: #1

December 10, 2024

2 min read

And the technology ranked first in our 2024 Innovation Awards is…

The Analytical Scientist Innovation Awards 2024
Spectroscopy
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

Affiliations:

Specialties:

Areas of Expertise:

Contributions:

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Your Privacy Choices
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.